The closing price of Moleculin Biotech Inc (NASDAQ: MBRX) was $0.42 for the day, down -19.70% from the previous closing price of $0.52. In other words, the price has decreased by -$0.1032 from its previous closing price. On the day, 955667 shares were traded.
Ratios:
Our analysis of MBRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.10 and its Current Ratio is at 7.10. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 26 ’23 when KLEMP WALTER V bought 188,404 shares for $0.69 per share. The transaction valued at 129,999 led to the insider holds 680,880 shares of the business.
Foster Jonathan P. bought 28,986 shares of MBRX for $20,000 on Dec 26 ’23. The Chief Financial Officer now owns 80,556 shares after completing the transaction at $0.69 per share. On Dec 26 ’23, another insider, George Robert E., who serves as the Director of the company, bought 14,493 shares for $0.69 each. As a result, the insider paid 10,000 and bolstered with 14,660 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBRX now has a Market Capitalization of 14.05M and an Enterprise Value of -10.03M.
Stock Price History:
Over the past 52 weeks, MBRX has reached a high of $1.65, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 0.5566, while the 200-Day Moving Average is calculated to be 0.5665.
Shares Statistics:
MBRX traded an average of 162.38K shares per day over the past three months and 190.66k shares per day over the past ten days. A total of 33.41M shares are outstanding, with a floating share count of 32.20M. Insiders hold about 3.62% of the company’s shares, while institutions hold 15.51% stake in the company. Shares short for MBRX as of Feb 29, 2024 were 134.43k with a Short Ratio of 0.83, compared to 220k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.40% and a Short% of Float of 0.42%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.2 for the current quarter, with a high estimate of -$0.19 and a low estimate of -$0.21, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.86 and -$0.87 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.78, with 3 analysts recommending between -$0.65 and -$0.98.
